Use of Cardiovascular Drugs for Primary and Secondary Prevention of Cardiovascular Disease Among Rural-Dwelling Older Chinese Adults
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of Cardiovascular Drugs for Primary and Secondary Prevention of Cardiovascular Disease Among Rural-Dwelling Older Chinese Adults
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-18
DOI
10.3389/fphar.2020.608136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterizing lipid profiles associated with asymptomatic intracranial arterial stenosis in rural-dwelling adults: A population-based study
- (2020) Shaoying Wang et al. Journal of Clinical Lipidology
- World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
- (2020) Miia Kivipelto et al. Alzheimers & Dementia
- Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis
- (2019) Tian-Tian Ma et al. PLoS One
- Burden of Cardiovascular Diseases in China, 1990-2016
- (2019) Shiwei Liu et al. JAMA Cardiology
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. CIRCULATION
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement
- (2019) Xin Du et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop
- (2018) Janice B. Schwartz et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Traditional Chinese Medicine for Cardiovascular Disease
- (2017) Panpan Hao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The primary health-care system in China
- (2017) Xi Li et al. LANCET
- Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)
- (2017) Jiapeng Lu et al. LANCET
- The Trends in Cardiovascular Diseases and Respiratory Diseases Mortality in Urban and Rural China, 1990–2015
- (2017) Weiwei Sun et al. International Journal of Environmental Research and Public Health
- Effects of Macronutrient Distribution on Weight and Related Cardiometabolic Profile in Healthy Non-Obese Chinese: A 6-month, Randomized Controlled-Feeding Trial
- (2017) Yi Wan et al. EBioMedicine
- Trends in the epidemiology of cardiovascular disease in the UK
- (2016) Prachi Bhatnagar et al. HEART
- Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
- (2016) Rasha Khatib et al. LANCET
- Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
- (2016) Maigeng Zhou et al. LANCET
- The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China
- (2016) Sarah Lewington et al. JAMA Internal Medicine
- Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease
- (2016) Kunal N. Karmali et al. JAMA Cardiology
- Cardiovascular disease in Europe — epidemiological update 2015
- (2015) Nick Townsend et al. EUROPEAN HEART JOURNAL
- The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
- (2015) Dongfeng Gu et al. PLOS MEDICINE
- Patterns of cardiovascular drugs prescribed for an elderly Swedish population
- (2014) Mozhu Ding et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5million people
- (2014) Yiping Chen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study
- (2014) Claire A Rushton et al. BMJ Open
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- China's Rural Public Health System Performance: A Cross-Sectional Study
- (2013) Miaomiao Tian et al. PLoS One
- Highly prevalent and poorly controlled cardiovascular risk factors among Chinese elderly people living in the rural community
- (2013) Aiqin Song et al. European Journal of Preventive Cardiology
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
- (2011) Sidney C. Smith et al. CIRCULATION
- Underuse of Antithrombotic Therapy Caused High Incidence of Ischemic Stroke in Patients with Atrial Fibrillation
- (2011) Hsiu-Chin Yu et al. International Journal of Stroke
- Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
- (2011) Salim Yusuf et al. LANCET
- Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World
- (2010) Laurens M. Niëns et al. PLOS MEDICINE
- Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy
- (2008) M. Stramba-Badiale EUROPEAN HEART JOURNAL
- China's health system performance
- (2008) Yuanli Liu et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started